A study of utility and safety of chest tube removal regardless of amount of pleural effusio

Phase 3

Recruiting

• Conditions: Primary lung cancer, Metastatic lung tumor, Benign lung tumor; Pulmonary resection, postoperative air leak, thoracic drainage

• Registration Number: JPRN-jRCT1032180389
• Lead Sponsor: Suzuki Kenji

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 172

Inclusion Criteria

Patients who underwent lobectomy or segmentectomy and the amount of pleural effusion > 300mL/24hr on Thopaz or Thopas plus on POD2

Exclusion Criteria

Patients without postoperative air leak

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence rate of postoperative respiratory adverse events (%)

Secondary Outcome Measures

Name	Time	Method
Treatment completion rate (%), Duration of drain placement (day), days of hospitalization (day), Postoperative pulmonary function